Three new studies give clear guidance on how to better recruit volunteers for Alzheimer’s clinical studies
Published 13 July 2009
Partnering with local physicians, working with local clinics, conducting educational seminars and health fairs were found to be the most effective tools in recruiting people for clinicical studies
'Clinical trials are very important. Not only do they drive forward dementia research but people who participate in clinical trials often experience positive benefits. Despite this a very small number of people are given the opportunity to participate in a dementia research trial. We must invest in clinical trials and use the unique value of the NHS to improve patient access to clinical trials. This will allow new treatments to reach people with dementia as soon as possible.
'Communication is also key. It is important to ensure that people are given practical information about available trials and realistic advice about selection.'
Professor Clive Ballard
Director of Research
Alzheimer's Society
Ends
Ref: Abstracts
Notes to editors
- International Conference of Alzheimer's Disease runs from 11 - 16 July 2009 for further information please visit ICAD
- One in three people over 65 will die with dementia
- Alzheimer's Society research shows that 700,000 people in the UK have a form of dementia, more than half have Alzheimer's disease. In less than 20 years nearly a million people will be living with dementia. This will soar to 1.7 million people by 2051.
- Alzheimer's Society champions the rights of people living with dementia and the millions of people who care for them.
- Alzheimer's Society works in England, Wales and Northern Ireland
- Alzheimer's Society needs to raise money to help people live well with
dementia today and for research to find a cure for tomorrow. You can
donate now by calling 0845 306 0898 or visiting alzheimers.org.uk
- Alzheimer's Society provides a National Dementia Helpline, the number is 0845 300 0336 or visit alzheimers.org.uk
